Woodworth Emily 4

What Happened Emily Woodworth, SVP, Global Controller and CAO of Boston Scientific (BSX), had restricted stock units (RSUs) convert to common shares on Feb 13, 14 and 16, 2026. A total of 2,711 shares vested (1,413 + 661 + 637). To satisfy tax withholding, 1,269 shares were withheld (690 + 296 + 283) at $74.73 per share for a total withholding value of $94,833. After withholding, she was issued a net 1,442 shares. This was a vesting/tax-withholding event (routine), not an open-market purchase or discretionary sale.

Key Details

• Transaction dates and actions:
  • Feb 13, 2026: 1,413 RSUs converted to shares (acquired at $0); 690 shares withheld for taxes at $74.73 ($51,564).
  • Feb 14, 2026: 661 RSUs converted; 296 shares withheld at $74.73 ($22,120).
  • Feb 16, 2026: 637 RSUs converted; 283 shares withheld at $74.73 ($21,149).
• Total vested: 2,711 shares. Total withheld for taxes: 1,269 shares (~$94,833). Net shares issued to Woodworth: 1,442 shares.
• Footnotes: F1–F4 indicate these were RSUs (each unit = 1 share) from multiple grants with staggered annual installment vesting schedules (grant anniversaries Feb 13, Feb 14, and Feb 16 of prior years).
• Transaction codes: M = exercise/conversion of derivative (RSU conversion); F = shares withheld to pay tax liability.
• Filing timeliness: Transactions dated Feb 13–16, 2026; Form 4 filed Feb 18, 2026. Form 4s are normally due within two business days, so the Feb 13 vesting appears to have been reported late.

Context

• This was a standard RSU vesting with shares withheld for taxes (cashless tax withholding), not an open-market sale or purchase signal. Tax-withholding disposals are routine and reflect tax obligations rather than a decision to monetize holdings.
• The filing does not, in this excerpt, state total shares Woodworth owns after these transactions beyond the net issued shares noted above.